Elaine Quilici

Peanut allergies raise fears among parents, teachers, but treatment is now available.

If not addressed, effects could impact innovation, diversity.

Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes outside of work to help raise awareness for cancer.

With a background in pharma and biotech, ImmunoGen president and CEO Mark Enyedy discusses his dedication to oncology and the lessons he’s learned along the way.

Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.

Biopharma leaders and experts gather to discuss the future of pharma collaboration and tackling critical public health needs—together.

Ester Banque, senior vice president and head of Intercontinental Commercial at Bristol Myers Squibb, talks purpose and perseverance—both in her own career journey and her group’s mission to topple barriers to drug access in diverse and hard-to-reach regions.

For leaders, shifting mindsets and altering dynamics can help.

Yan Chen, CEO of Elpis Biopharmaceuticals, talks about how she transitioned her career from scientist to CEO and what that has entailed.

Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.

Latino executives share their experiences and insights on the community’s contributions to the life sciences industry.

Give your team members opportunities to lead for greater growth.

Looking back at 2000-2002.

Emma Chaffin, vice president and country head of Galapagos UK, discusses how her personal journey with cancer put a spin on her life, including her career in pharma.

Teresa Bitetti, President of Takeda Pharmaceuticals’ Global Oncology Business Unit, talks about her experience as a leader in the oncology space and what that entails in today’s environment.

Judy Stewart, head of US vaccines at GSK, talks about the effects of people missing their recommended vaccinations during the pandemic and the importance of delivering a message of value for vaccines.

Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.

College roommates, industry partnerships help bring Pfizer vaccine to fruition.

Leading in a post-quarantine world requires compassion and connection amid employees’ shifting situations.

Mike Starich, CEO of Orion Talent, and Dr. Armand Balboni, CEO of Appili Therapeutics, talk about hiring veterans for roles in pharma, and how the industry can capitalize on their unique qualifications.

Our editorial team presents the winners of our annual Emerging Pharma Leaders and their up-and-coming perspectives on a range of industry topics.

Sandor Schoichet, an independent advisor and director of Meridian Management Consultants based in San Francisco, and Thomas Scheiwiller, an independent advisor and board member based in Zurich, talk about integrating environmental, social, and governance, or ESG, issues into biopharma business planning, and communicating with capital investors about these areas.

Learning from others and leading by example provides full-circle success.

Startup CEO touts immunology technology to cure cancer and more.

Academic-focused leader advocates questioning and communicating to advance science.

A deeper understanding of the differing age-group dynamics is key.

Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.

John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as a young man in Ireland, and how those tenets can translate to the C-suite.

The Healthcare Businesswomen’s Association again names Sandra Horning its WoTY—where the pharma leader’s message of purpose and partnership takes on added resonance today.

How open, two-way communication can help leaders to improve.